Key result
Non-invasive imaging leads for stable chest pain and pre-TAVR evaluation, while ICA remains dominant for STEMI.
Why the study?
Non-invasive imaging modalities have expanded the range of clinical questions answerable without an intra-arterial catheter, but this shift from invasive coronary angiography has been uneven across clinical domains.
Does non-invasive imaging replace invasive coronary angiography as the first-line investigation in patients with suspected cardiovascular disease?
Does non-invasive imaging replace invasive coronary angiography as the first-line investigation in patients with suspected cardiovascular disease?
This review provides a complexity-stratified framework for choosing between non-invasive and invasive angiographic investigation across different cardiovascular disease domains.
Answers are grounded in this paper and cite their sources.
Reinforces domain-specific first-line imaging choices; extends 2009-2026 evidence synthesis without altering high-risk invasive standards.
Background: Invasive coronary angiography has historically been the reference standard for coronary, valvular, and structural heart disease. Over the past decade, coronary computed tomography angiography (CCTA), CT-derived fractional flow reserve (CT-FFR), photon-counting detector computed tomography (PCCT), and cardiac magnetic resonance (CMR) have expanded the range of clinical questions answerable without an intra-arterial catheter, but this shift has been uneven across clinical domains. Methods: We performed a narrative review and synthesis of randomized trials, registries, society guidelines, and consensus documents (2009–2026) identified through PubMed and major cardiovascular guideline databases, written from a joint cardiology and cardiac-surgical standpoint. Results: The boundary has shifted asymmetrically, by which we mean a domain-dependent rather than uniform displacement of invasive angiography. Non-invasive imaging is now established as the first-line approach for stable chest pain at low-to-moderate pretest probability, for pre-transcatheter aortic valve replacement (TAVR) and structural procedural planning, and for aortic disease. It remains contested for stable multivessel disease and pre-coronary artery bypass grafting (CABG) planning, where CCTA- or CT-FFR-only planning is still investigational. Invasive angiography stays first-line for ST-elevation myocardial infarction (STEMI), cardiogenic shock, and complex percutaneous coronary intervention (PCI), where diagnosis and therapy are inseparable. Conclusions: Invasive and non-invasive modalities are complementary rather than competing. The appropriate first-line investigation depends on the disease domain, pretest probability, anatomical complexity, imaging quality, and whether diagnosis and treatment can be separated. We propose a complexity-stratified, heart-team framework and identify the surgical research gaps that remain.
No takes yet. Share an insight, caveat, or question.
Ren et al. (2026) conducted a review in Coronary, valvular, and structural heart disease. Non-invasive imaging (CCTA, CT-FFR, PCCT, CMR) vs. Invasive coronary angiography (ICA) was evaluated. Non-invasive imaging is established as first-line for stable chest pain at low-to-moderate pretest probability, pre-TAVR, and aortic disease, while invasive angiography remains first-line for STEMI, cardiogenic shock, and complex PCI.
Synapse has enriched 10 related papers. Consider them for comparative context: